Inova Alexandria Hospital Physicians Performs First Magellan™ Robot-Assisted Endovascular Procedure in Mid-Atlantic Region

ALEXANDRIA, VA – December 18, 2014 – Inova, a leader in world-class healthcare, has announced the successful completion of the first robot-assisted endovascular procedure in the Mid-Atlantic region. Keith Sterling, MD, Director of Cardiovascular and Interventional Radiology and Sandeep Bagla, MD, performed a robot-assisted Ovarian Vein Embolization procedure for the treatment of Pelvic Congestion Syndrome at Inova Alexandria Hospital in Alexandria, Virginia using the Magellan Robotic System (Hansen Medical, Inc., Mountain View, California, NASDAQ: HNSN). This was the first robot-assisted Ovarian Vein Embolization in the United States.

“I am extremely pleased by the outcome of this initial procedure with the Magellan Robotic System at Inova,” said Dr. Sterling. “Robotic catheters have the potential to provide enhanced precision and control, especially when navigating in the small, often tortuous blood vessels involved in embolization procedures. We look forward to expanding our use of the Magellan Robotic System to include other complex endovascular procedures in the near future.”

Pelvic Congestion Syndrome results in chronic pain in the pelvis and lower abdomen caused by varicose veins that occur when valves in the veins do not work properly and allow the blood to flow backwards and pool. Over 30% of women will experience chronic pelvic pain in their lifetime, and Pelvic Congestion Syndrome is a factor in almost 50% of these cases. The syndrome is most common in women age 20-45 who have had multiple pregnancies.

Ovarian Vein Embolization (OVE) is a non-surgical procedure in which a catheter is used to deliver treatment to block the varicose vein that is causing pain. Compared to alternative treatments, such as pain medication or surgery, OVE is less invasive, allows for a faster recovery and is proven to be safe and effective with results showing around an 80-90% reduction in pain.

The Magellan Robotic System offers precise robotic catheter control and stability during complex procedures in the peripheral blood vessels, and is used by physicians worldwide in a wide variety of catheter-based procedures. With the recent FDA 510(k) clearance for the smaller diameter Magellan 6Fr Robotic Catheter, physicians are now able to perform robotic procedures in smaller blood vessels, including those accessed during an Ovarian Vein Embolization.

“Congratulations to Dr. Sterling, Dr. Bagla and their entire team on this exciting milestone,” said Susan Carroll, Interim CEO, Inova Alexandria Hospital. “We are extremely proud to see the ground breaking work that our physicians and staff are doing on behalf of their patients here at Inova. The recent introduction of the Magellan Robotic System to our endovascular program demonstrates our commitment to providing the most advanced technologies available to ensure the highest quality care for our patients.”